RT Journal Article SR Electronic T1 MHRA DOAC safety reminder JF Drug and Therapeutics Bulletin JO Drug Ther Bull FD BMJ Publishing Group Ltd SP 150 OP 150 DO 10.1136/dtb.2020.000047 VO 58 IS 10 YR 2020 UL http://dtb.bmj.com/content/58/10/150.abstract AB Review of: Medicines and Healthcare products Regulatory Agency. Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents. Drug Safety Update 2020;13(11):1